Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Pantoprazole Sodium for Injection, 40 mg/vial (single-dose vial). This product is expected to be launched in Q1 FY16-17. The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Protonix I.V. for Injection, 40 mg/vial, of Wyeth Pharmaceuticals, Inc.
Pantoprazole Sodium for Injection is a gastrointestinal drug used in the treatment of gastroesophageal reflux disease (GERD) associated with the history of erosive esophagitis. It is also indicated for the treatment of pathological hypersecretory conditions including Zollinger-Ellison syndrome in adults. The approved product has an estimated market size of $ 93.5 million for the twelve months ending February 2016 according to IMS.
This is the 29th ANDA (including two tentative approvals) to be approved out of Unit IV formulation facility in Hyderabad, India used for manufacturing general injectable products. Aurobindo now has a total of 249 ANDA approvals (213 Final approvals including 10 from Aurolife Pharma LLC and 36 tentative approvals) from USFDA.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: